Novo Nordisk held a conference call Conference call to discuss the FDA's Comoplete Response Letter for Tresiba(r) and Ryzodeg(r) was held on February 11 at 2 am and has a replay available until February 18 at 6 pm. Webcast Link
News For NVO From The Last 14 Days
Check below for free stories on NVO the last two weeks.
Subscribe for More Information